{"id":1068278,"date":"2022-11-05T01:42:21","date_gmt":"2022-11-05T05:42:21","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/terns-pharmaceuticals-highlights-results-from-phase-1-clinical-trial-of-tern-501-at-aasld-the-liver-meeting-2022\/"},"modified":"2024-08-18T11:45:16","modified_gmt":"2024-08-18T15:45:16","slug":"terns-pharmaceuticals-highlights-results-from-phase-1-clinical-trial-of-tern-501-at-aasld-the-liver-meeting-2022","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/terns-pharmaceuticals-highlights-results-from-phase-1-clinical-trial-of-tern-501-at-aasld-the-liver-meeting-2022.php","title":{"rendered":"Terns Pharmaceuticals Highlights Results from Phase 1 Clinical Trial of TERN-501 at AASLD The Liver Meeting\u00ae 2022"},"content":{"rendered":"<p><![CDATA[Data demonstrated treatment with TERN-501 resulted in time- and dose-dependent increases in sex hormone binding globulin (SHBG), a key marker linked to NASH histologic efficacy]]><\/p>\n<p>Read more from the original source:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2022\/11\/04\/2548732\/0\/en\/Terns-Pharmaceuticals-Highlights-Results-from-Phase-1-Clinical-Trial-of-TERN-501-at-AASLD-The-Liver-Meeting-2022.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Terns Pharmaceuticals Highlights Results from Phase 1 Clinical Trial of TERN-501 at AASLD The Liver Meeting\u00ae 2022\">Terns Pharmaceuticals Highlights Results from Phase 1 Clinical Trial of TERN-501 at AASLD The Liver Meeting\u00ae 2022<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Read more from the original source: Terns Pharmaceuticals Highlights Results from Phase 1 Clinical Trial of TERN-501 at AASLD The Liver Meeting\u00ae 2022 <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/terns-pharmaceuticals-highlights-results-from-phase-1-clinical-trial-of-tern-501-at-aasld-the-liver-meeting-2022.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1068278","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068278"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1068278"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068278\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1068278"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1068278"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1068278"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}